Elevated ADMA levels may contribute to obesity via multiple mechanisms, such as interfering with insulin signal transduction and glucose metabolism, activating CaSR to promote lipid accumulation, and disrupting hepatic lipid metabolism (33–35). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.